Janssen Research and Development, New Jersey, United States
Johnson and Johnson (Employment)
OP-26C - Sensitivity Analysis of Design Choices for Estimating Incidence Rates of Adverse Events of Special Interest in Vaccine Safety
Monday, August 23, 20211:45 PM – 3:30 PM US Eastern Time
OP-5A - Descriptive Epidemiology of Adverse Events of Special Interest for COVID-19 Vaccines Across 7 Countries and 4 Continents: A Multinational Network Cohort Study
Wednesday, August 25, 202111:45 AM – 1:30 PM US Eastern Time